EspeRare_POST- EDELIFE

What is the Purpose of this Study?

Primary: to assess the long-term (4 and 5 years of age) efficacy of intra-amniotic administrations of ER004 on sweating ability (sweat volume) in male XLHED subjects with a null mutation in EDA. Secondary: ? To assess the long-term efficacy of intra-amniotic administrations of ER004 on sweat pore density, dentition, dry eyes issues, eczema, salivation and XLHED-related hospitalization in male subjects with XLHED ? To assess the long-term safety of intra-amniotic administrations of ER004 in male subjects with XLHED


Eligibility

Not Available


Where can I participate?

Beverly


What is the full name of this clinical trial?

Evaluation of Safety and Efficacy of ER004 Post-Intra-Amniotic Treatment in Males with XLHED

Study Details
Disease Type/Condition

Other

Principal Investigator

Klein, Ophir

Co-Investigators

Allison Truong, Pedro Sanchez

Age Group

Children

Phase

N/A

IRB Number

STUDY00003816


How do I learn more about this study?
Email
clinicaltrials@cshs.org
Study Detail
Disease Type/Condition

Other

Principal Investigator

Klein, Ophir

Age Group

Children

Phase

N/A

IRB Number

POST-EDELIFE


Contact
Email
clinicaltrials@cshs.org